Sensus Healthcare CEO Joseph Sardano Buys 20,000 Shares

What Happened
Joseph C. Sardano, CEO of Sensus Healthcare (SRTS), reported an open-market purchase of 20,000 shares on August 20, 2026 at $3.02 per share, for a total cash outlay of approximately $60,486. This was a direct purchase (transaction code P), which represents an insider buy rather than a sale or option exercise.

Key Details

• Transaction date: 2026-08-20; Price: $3.02 per share; Shares acquired: 20,000; Total ≈ $60,486.
• Transaction type: Open market purchase (Code P).
• Shares owned after transaction: Not specified in the provided filing details.
• Filing date / accession: Form 4 filed 2026-08-24 (Accession No. 0001300111-26-000002). The Form 4 was filed four days after the trade date, which appears to exceed the typical 2-business-day SEC reporting window and may be late.
• No 10b5-1 plan, tax-withholding, or other special footnotes were noted in the provided transaction summary.

Context
Insider purchases can be seen as a positive signal because they involve executives buying company stock with personal funds, but a single small purchase (~$60k) is limited information on its own. This was a straightforward open-market buy — not an option exercise, gift, or award. Retail investors should view this as one data point among many (company fundamentals, broader insider activity, and market conditions).